Back
Fifth Third Bancorp 10K Form
Buy
63
FITB
Fifth Third Bancorp
Last Price:
$50.87
Seasonality Move:
2.49%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2026-01-15 | 10K | FITB/Fifth Third Bancorp Annual |
| 2025-12-15 | 10K | FITB/Fifth Third Bancorp Annual |
| 2025-11-15 | 10K | FITB/Fifth Third Bancorp Annual |
| 2025-10-15 | 10K | FITB/Fifth Third Bancorp Annual |
| 2025-09-15 | 10K | FITB/Fifth Third Bancorp Annual |
| 2024-05-07 | 10Q | FITB/Fifth Third Bancorp Quarterly |
Receive FITB News And Ratings
See the #1 stock for the next 7 days that we like better than FITB
FITB Financial Statistics
Sales & Book Value
| Annual Sales: | $12.9B |
|---|---|
| Cash Flow: | $824M |
| Price / Cash Flow: | 11.67 |
| Annual Sales: | $30.18 |
| Price / Book: | 1.67 |
Profitability
| EPS (TTM): | 3.53480 |
|---|---|
| Net Income (TTM): | $2.5B |
| Gross Margin: | $0 |
| Return on Equity: | 12.13% |
| Return on Assets: | 1.19% |
Fifth Third Bancorp Earnings Forecast
Key Fifth Third Bancorp Financial Ratios
-
The Gross Profit Margin over the past 46 years for FITB is 0.00%.
-
The Selling, General & Administrative Expenses for FITB have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 38.42% of Operating Income.
-
The Net Earning history of FITB is 19.49% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 29 years.
Fifth Third Bancorp Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Banks |
| Sector: | Financials |
| Current Symbol: | FITB |
| CUSIP: | 316773 |
| Website: | 53.com |
Debt
| Debt-to-Equity Ratio: | 0.67 |
|---|---|
| Current Ratio: | 0.28 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 14.29 |
|---|---|
| Forward P/E Ratio: | 10.17 |
FITB Technical Analysis vs Fundamental Analysis
Buy
63
Fifth Third Bancorp (FITB)
is a Buy
Is Fifth Third Bancorp a Buy or a Sell?
-
Fifth Third Bancorp stock is rated a BuyThe current Fifth Third Bancorp [FITB] share price is $50.49. The Score for FITB is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.